Castle Creek Arbitrage’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Castle Creek Arbitrage’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-600,000	Closed	-$6.25M	–	453
2023 Q1	$6.25M	Hold	600,000	–	–	0.69%	33
2022 Q4	$6.11M	Buy	+600,000	New	+$6.07M	0.54%	52

Castle Creek Arbitrage's LVAC Position: Q2 2023 in Review

Castle Creek Arbitrage sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 600,000 shares — an estimated $6.25M sold.

Castle Creek Arbitrage first reported a position in LVAC in Q4 2022 and held it in 2 quarters. The position peaked at $6.25M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Castle Creek Arbitrage reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 600,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $6.25M.
Castle Creek Arbitrage first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 2 quarters.
Castle Creek Arbitrage's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $6.25M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Castle Creek Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.